Publication | Open Access
Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility
410
Citations
30
References
1992
Year
ImmunologyAntigen ProcessingHyaluronan ReceptorCytoskeletonCellular PhysiologyTumor BiologyProtein ExpressionCancer Cell BiologyMatrix BiologyTumor Cell MotilityCell SignalingUnique Hyaluronan ReceptorProtein FunctionCell TraffickingReceptor (Biochemistry)Molecular CloningCell BiologyBiomolecular EngineeringNovel Hyaluronan ReceptorSignal TransductionCell-matrix InteractionCell MigrationMedicineExtracellular Matrix
A cDNA encoding a unique hyaluronan receptor has been molecularly cloned from a lambda GT11 3T3 cDNA expression library. Immunoblot analyses of cell lysates, using antibodies to peptides encoded in the cDNA, specifically react with a 58-kD protein. This protein is regulated by the mutant H-ras gene in cells containing a metallothionein promoter H-ras hybrid gene. Further, antibodies to peptide sequences encoded in the cDNA block the increase in locomotion resulting from induction of the mutant H-ras gene in this cell line. In a transblot assay, the bacterially expressed protein binds to biotinylated hyaluronan. Antibodies to peptides encoded in the cDNA react in immunoblot assays with the 58- and 52-kD proteins of a novel hyaluronan receptor complex previously implicated in cell locomotion. Furthermore, antibodies specific to the 58- and 52-kD proteins, which block ras-induced locomotion, also cross-react with the expressed, encoded protein. The gene product described here appears to be a new type of hyaluronan receptor that is involved in cell locomotion. It is named RHAMM, an acronym for receptor for hyaluronan-mediated motility.
| Year | Citations | |
|---|---|---|
Page 1
Page 1